![Damian Clarke-Bruce](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Damian Clarke-Bruce worked as Executive Director-Global Marketing at Pharming Group NV from 2020 to 2023.
In 2023, served as Chief Executive Officer, MD & Director at Racura Oncology Ltd. Also in 2023, took the role of Chief Executive Officer & Director at HaemaLogiX Pty Ltd. Education includes undergraduate studies at The University of New South Wales, graduate degrees from Macquarie University, and The University of Sydney.
Former positions of Damian Clarke-Bruce
| Companies | Position | End |
|---|---|---|
HaemaLogiX Pty Ltd.
 HaemaLogiX Pty Ltd. BiotechnologyHealth Technology Develops immunotherapies for blood cancers and B cell disorders | Chief Executive Officer | 2026-01-04 |
| RACURA ONCOLOGY LTD | Chief Executive Officer | 2023-08-21 |
| PHARMING GROUP N.V. | Sales & Marketing | 2022-12-31 |
Training of Damian Clarke-Bruce
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
4
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Pharming Group NV
 Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
The University of New South Wales
 The University of New South Wales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Macquarie University
 Macquarie University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Sydney
 The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Race Oncology Ltd.
 Race Oncology Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for cancer | Health Technology |
HaemaLogiX Pty Ltd.
HaemaLogiX Pty Ltd. BiotechnologyHealth Technology Develops immunotherapies for blood cancers and B cell disorders | Health Technology |
- Stock Market
- Insiders
- Damian Clarke-Bruce
